Yahoo
Frankfurt - Delayed Quote EUR

Cochlear Limited (OC5.F)

93.45 +0.11 (+0.12%)
As of 8:03:20 AM GMT+1. Market Open.
Chart Range Bar
Loading chart for OC5.F
  • Previous Close 93.34
  • Open 93.45
  • Bid 92.51 x 20000
  • Ask 95.23 x 20000
  • Day's Range 93.45 - 93.45
  • 52 Week Range 55.17 - 161.58
  • Volume 20
  • Avg. Volume 11
  • Market Cap (intraday) 6.112B
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) 71.34
  • EPS (TTM) 1.31
  • Earnings Date Aug 18, 2026
  • Forward Dividend & Yield 1.62 (1.70%)
  • Ex-Dividend Date Sep 21, 2026
  • 1y Target Est --

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

www.cochlear.com

5,400

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/10/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

OC5.F
34.67%
S&P/ASX 200 [XJO] (^AXJO)
4.76%

1-Year Return

OC5.F
38.94%
S&P/ASX 200 [XJO] (^AXJO)
3.52%

3-Year Return

OC5.F
32.36%
S&P/ASX 200 [XJO] (^AXJO)
30.85%

5-Year Return

OC5.F
24.63%
S&P/ASX 200 [XJO] (^AXJO)
23.67%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.27%

  • Return on Assets (ttm)

    9.71%

  • Return on Equity (ttm)

    7.98%

  • Revenue (ttm)

    2.35B

  • Net Income Avi to Common (ttm)

    147.3M

  • Diluted EPS (ttm)

    1.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    187.7M

  • Total Debt/Equity (mrq)

    12.22%

  • Levered Free Cash Flow (ttm)

    313.59M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: